• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Up 0.14%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    5.71 Up 0.01(0.18%) May 26, 4:00PM EDT
    Prev Close:5.70
    Open:5.72
    Bid:5.20 x 5000
    Ask:6.45 x 500
    1y Target Est:8.15
    Beta:3.04503
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:5.66 - 5.89
    52wk Range:2.80 - 10.80
    Volume:835,797
    Avg Vol (3m):1,756,880
    Market Cap:604.24M
    P/E (ttm):N/A
    EPS (ttm):-1.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 0.18%604.24M
    BAXDown 0.16%23.98B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31.20
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.96
    Quarterly EPS Est (Jun-16) :-0.27
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback